Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys

By Nagata N.   Iwasaki T.   Ami Y.   Harashima A.   Hatano I.   Suzaki Y.   Yoshii K.   Yoshii T.   Nomoto A.   Kurata T.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3201-3208

Elsevier

Access to resources Recommend Favorite

Inactivated poliovirus vaccine: past and present experience

By Murdin A.D.   Barreto L.   Plotkin S.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 735-746

Elsevier

Access to resources Recommend Favorite

TgPVR21 mice for testing type-3 oral poliovirus vaccines: role of clinical observation and histological examination

By Dragunsky E.   Chernokhvostova Y.   Taffs R.   Chumakov K.   Gardner D.   Asher D.   Nomura T.   Hioki K.   Levenbook I.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1863-1866

Elsevier

Access to resources Recommend Favorite

Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants

By Migasena S.   Simasathien S.   Samakoses R.   Pitisuttitham P.   Sangaroon P.   van Steenis G.   Beuvery E.C.   Bugg H.   Bishop R.   Davidson B.L.   Vesikari T.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 168-174

Elsevier

Access to resources Recommend Favorite

Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules

By du Chatelet I.P.   Merchant A.T.   Fisher-Hoch S.   Luby S.P.   Plotkin S.A.   Moatter T.   Agboatwalla M.   Mc Cormick J.B.  

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1710-1718

Elsevier

Access to resources Recommend Favorite